Femtosecond Laser Cleared By FDA

Home
Cataract
Cornea
Glaucoma
Refractive
Retina
Practice Management

Friday, August 10, 2012

Ophthalmology Times

Bausch + Lomb (B + L) and Technolas Perfect Vision GmbH (TPV) have received 510(k) clearance from the FDA for a femtosecond laser platform (Victus), and it is now available for shipment within the United States.

Full Story

The glaucoma medications associated with decreased conjunctival goblet cell density are:
1. Prostaglandin analogs
2. Selective beta blockers
3. Non-selective beta blockers
4. Alpha agonists
Check The Answer

PanoCam™ LT Wide-field Digital Imaging System
The PanoCam LT represents the first ... view product
Volk iNview
iPhone Fundus Camera The Volk iNview ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Femtosecond Laser Cleared By FDA

Comments

Quick Quiz

The glaucoma medications associated with decreased conjunctival goblet cell density are:

AdGlare RMR Ad

Featured Products

PanoCam™ LT Wide-field Digital Imaging System

Volk iNview

Follow OphthalmologyWeb

Write for Us

AdGlare RMR2